Immune thrombocytopenia (ITP): vizsgálatok itt: Németország
13 of 14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Where
- Berlin, Cologne, Freiburg im Breisgau, Heidelberg
- Életkor
- 12 év to 17 év
- People
- 24 worldwide
- Run by
- argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Where
- Berlin, Dresden, Essen, Frankfurt Am Main, Giessen, Jena, Leipzig
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00 - 1/2. fázisNot yet taking people in NémetországAn Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1
- Where
- Tuebingen
- Életkor
- 18 év to 80 év
- People
- 36
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07932262 · EU 2024-519491-60-00 - 3. fázisBefejeződöttA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Essen, Jena, Mannheim
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 1. fázisTaking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Dresden, Erlangen, Goettingen, Luebeck, Rüdersdorf, Tuebingen
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - 3. fázisBefejeződöttA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Essen, Jena, Mannheim
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 3. fázisTaking peopleA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- Where
- Frankfurt Am Main
- Életkor
- 18 év to 70 év
- People
- 40 worldwide
- Run by
- Kedrion S.p.A.
See details and how to joinNCT07059000 · EU 2023-507115-35-00 - 1/2. fázisTaking peopleSafety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Where
- Cologne, Dresden, Hanover, Mainz
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07549698 - 2. fázisNot yet taking people in NémetországStudy of Zola-cel (BMS-986353), CD19 NEX-T CAR T Cells in Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Erlangen, Magdeburg
- Életkor
- 18 év and over
- People
- 3 worldwide
- Run by
- Celgene Corp.
See details and how to join2025-524993-41-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Dresden, Erlangen, Goettingen, Rüdersdorf, Tuebingen
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Erlangen, Göttingen, Lübeck, Sachsen, Tübingen
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 2. fázisNot yet taking people in NémetországStudy of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Erlangen, Magdeburg
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07603557 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- Dresden, Essen
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00